Cutler Group’s IDEAYA Biosciences IDYA Stock Holding History

Cutler Group’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$2K	–	4021
2023 Q2	$2K	Buy	+100	New	+$2.06K	﹤0.01%	3033

Other funds holding IDYA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Cutler Group's IDYA Position: Q3 2023 in Review

Cutler Group sold out of IDEAYA Biosciences (IDYA) in Q3 2023, closing a stake of 100 shares — an estimated $2K sold.

Cutler Group first reported a position in IDYA in Q2 2023 and held it in 1 quarter. The position peaked at $2K in Q2 2023. 144 funds tracked by Wall St. Rank hold IDYA as of Q3 2023.

Cutler Group reported no remaining IDEAYA Biosciences position as of Q3 2023 after selling out during the quarter.
Cutler Group sold 100 IDEAYA Biosciences shares in Q3 2023, an estimated $2K.
Cutler Group first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 1 quarter.
Cutler Group's IDEAYA Biosciences position peaked at $2K in Q2 2023.
144 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.